2型糖尿病大血管并发症的防治进展  

Advances in prevention and treatment of macrovascular complications in type 2 diabetes

作　　者：蒋飞霞[1] 苏宏业[1] 黄济华 JIANG Feixia;SU Hongye;HUANG Jihua(Department of Endocrinology,the Second Affiliated Hospital of Guangxi Medical University,Nanning 530007,China)

机构地区：[1]广西医科大学第二附属医院内分泌科,广西南宁530007

出　　处：《中国现代医生》2018年第22期156-160,共5页China Modern Doctor

摘　　要：随着人们生活方式的改变,2型糖尿病的患病率在逐年增高,成为危及人类健康的主要疾病。2型糖尿病会引起大血管及微血管等并发症,其中大血管并发症包括冠心病、缺血性脑卒中及外周动脉疾病,是2型糖尿病致死和致残的主要原因。大血管并发症的主要危险因素包括高血糖、高血压、血脂异常、肥胖、血液高凝状态等。本文对2型糖尿病大血管并发症的防治进展做一综述。With the change of people＇s lifestyle,the prevalence of type 2 diabetes has been increasing year by year and the type 2 diabetes has become a major disease that threatens human health.Type 2 diabetes can cause complications such as large blood vessels and microvessels.Among them,macrovascular complications,including coronary heart disease,ischemic stroke,and peripheral arterial disease,are the major causes of death and disability in type 2 diabetes.Major risk factors for macrovascular complications include hyperglycemia,hypertension,dyslipidemia,obesity and hypercoagulability.This article reviews the advances in prevention and treatment of macrovascular complications in type 2 diabetes.

关 键 词：2型糖尿病 血管 并发症 干预 

分 类 号：R587.1[医药卫生—内分泌]